Logo

U.S. FDA Approves Cyltezo (adalimumab-adbm) as First Interchangeable Biosimilar with Humira

Share this
U.S. FDA Approves Cyltezo (adalimumab-adbm) as First Interchangeable Biosimilar with Humira

U.S. FDA Approves Cyltezo (adalimumab-adbm) as First Interchangeable Biosimilar with Humira

Share this article on WhatsApp, LinkedIn and Twitter



Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions